at least 4 partial seizures in each 4 week period during the last 8 weeks prior to screening currently treated with 1 or 2 AEDs any except oxcarbazepine and felbamate in a stable dose regimen during at least 2 months prior to screening patients using vigabatrin should have been on this medication for at least 1 year with no deficit in visual field identified 